196 related articles for article (PubMed ID: 4028024)
1. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
[TBL] [Abstract][Full Text] [Related]
2. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
Carrel S; Schreyer M; Gross N; Zografos L
Anticancer Res; 1990; 10(1):81-9. PubMed ID: 1692197
[TBL] [Abstract][Full Text] [Related]
3. Common phenotypic expression of gangliosides GM3 and GD3 in normal human tissues and neoplastic skin lesions.
Nakakuma H; Horikawa K; Kawaguchi T; Hidaka M; Nagakura S; Hirai S; Kageshita T; Ono T; Kagimoto T; Iwamori M
Jpn J Clin Oncol; 1992 Oct; 22(5):308-12. PubMed ID: 1469793
[TBL] [Abstract][Full Text] [Related]
4. Ganglioside, adhesion molecule, and HLA antigen expression in basal cell carcinoma lesions.
Kageshita T; Ono T; Hirai S; Yoshii A; Kimura T; Nakakuma H; Horikawa K; Takatsuki K; Ferrone S
Cancer Res; 1992 Jun; 52(11):3201-7. PubMed ID: 1350511
[TBL] [Abstract][Full Text] [Related]
5. The differential reactivity of cells of the melanocytic lineage with four monoclonal antibodies against IFN-gamma inducible molecules.
Vacca A; Frassanito A; Rimoldi D; Dammacco F; Carrel S
Anticancer Res; 1992; 12(1):1-9. PubMed ID: 1348919
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the colorectal carcinoma-associated antigen defined by monoclonal antibody D612.
Fernsten PD; Primus FJ; Greiner JW; Simpson JF; Schlom J
Cancer Res; 1991 Feb; 51(3):926-34. PubMed ID: 1988133
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of the A4 and AO10 (gp110) cell-surface antigens of human astrocytoma.
Garin-Chesa P; Beresford HR; Walker S; Rettig WJ
Am J Pathol; 1990 Apr; 136(4):797-807. PubMed ID: 2183624
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of melanoma associated antigens in acral lentiginous melanoma and in nodular melanoma lesions.
Kageshita T; Nakamura T; Yamada M; Kuriya N; Arao T; Ferrone S
Cancer Res; 1991 Mar; 51(6):1726-32. PubMed ID: 1671829
[TBL] [Abstract][Full Text] [Related]
9. A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels.
Shockley TR; Lin K; Sung C; Nagy JA; Tompkins RG; Dedrick RL; Dvorak HF; Yarmush ML
Cancer Res; 1992 Jan; 52(2):357-66. PubMed ID: 1728407
[TBL] [Abstract][Full Text] [Related]
10. Antigen expression in canine tissues, recognized by a monoclonal antibody generated against canine melanoma cells.
Oliver JL; Wolfe LG
Am J Vet Res; 1992 Jan; 53(1):123-8. PubMed ID: 1539903
[TBL] [Abstract][Full Text] [Related]
11. Malignant transformation of human melanocytes: induction of a complete melanoma phenotype and genotype.
Albino AP; Sozzi G; Nanus DM; Jhanwar SC; Houghton AN
Oncogene; 1992 Nov; 7(11):2315-21. PubMed ID: 1437153
[TBL] [Abstract][Full Text] [Related]
12. Spatial distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.
Shockley TR; Lin K; Nagy JA; Tompkins RG; Yarmush ML; Dvorak HF
Cancer Res; 1992 Jan; 52(2):367-76. PubMed ID: 1728408
[TBL] [Abstract][Full Text] [Related]
13. Cell surface accessibility of individual gangliosides in malignant melanoma cells to antibodies is influenced by the total ganglioside composition of the cells.
Lloyd KO; Gordon CM; Thampoe IJ; DiBenedetto C
Cancer Res; 1992 Sep; 52(18):4948-53. PubMed ID: 1516051
[TBL] [Abstract][Full Text] [Related]
14. Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen.
Stinson SF; Alley MC; Kopp WC; Fiebig HH; Mullendore LA; Pittman AF; Kenney S; Keller J; Boyd MR
Anticancer Res; 1992; 12(4):1035-53. PubMed ID: 1503399
[TBL] [Abstract][Full Text] [Related]
15. Homophilic binding of mouse monoclonal antibodies against GD3 ganglioside.
Chapman PB; Yuasa H; Houghton AN
J Immunol; 1990 Aug; 145(3):891-8. PubMed ID: 1695649
[TBL] [Abstract][Full Text] [Related]
16. Light chain variants of an IgG3 anti-GD3 monoclonal antibody and the relationship among avidity, effector functions, tumor targeting, and antitumor activity.
Chapman PB; Lonberg M; Houghton AN
Cancer Res; 1990 Mar; 50(5):1503-9. PubMed ID: 2105840
[TBL] [Abstract][Full Text] [Related]
17. [Mouse monoclonal antibody (FKH1) detecting human melanoma-associated antigens: production, partial characterization and immunohistochemical analysis].
Fukaya T
Hokkaido Igaku Zasshi; 1991 May; 66(3):300-10. PubMed ID: 1885156
[TBL] [Abstract][Full Text] [Related]
18. Immunorecognition of different ganglioside epitopes on human normal and melanoma tissues.
Bernhard H; Roth S; Bauerschmitz J; Meyer zum Büschenfelde KH; Dippold W
Int J Cancer; 1992 Jun; 51(4):568-72. PubMed ID: 1376299
[TBL] [Abstract][Full Text] [Related]
19. Identification of immunogenic human melanoma antigens in a polyvalent melanoma vaccine.
Bystryn JC; Henn M; Li J; Shroba S
Cancer Res; 1992 Nov; 52(21):5948-53. PubMed ID: 1382848
[TBL] [Abstract][Full Text] [Related]
20. Characterization of tenascin secreted by human melanoma cells.
Herlyn M; Graeven U; Speicher D; Sela BA; Bennicelli JL; Kath R; Guerry D
Cancer Res; 1991 Sep; 51(18):4853-8. PubMed ID: 1716515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
